silybin has been researched along with Hepatic Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alavizadeh, SH; Doagooyan, M; Gheybi, F; Hoseinian, A; Houshangi, K; Jaafari, MR; Khoddamipour, Z; Khooei, A; Papi, A; Sahebkar, A | 1 |
| Bosch-Barrera, J; Brunet, J; Corominas-Faja, B; Cuyàs, E; Martin-Castillo, B; Menendez, JA | 1 |
| Bahra, M; Berg, T; Biermer, M; Boas-Knoop, S; Eurich, D; Neuhaus, P; Neuhaus, R; Neumann, U | 1 |
3 other study(ies) available for silybin and Hepatic Failure
| Article | Year |
|---|---|
Alleviation of acetaminophen-induced liver failure using silibinin nanoliposomes: An in vivo study.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Lipids; Liposomes; Liver; Liver Failure; Mice; NIH 3T3 Cells; Reactive Oxygen Species; Silybin | 2023 |
Silibinin administration improves hepatic failure due to extensive liver infiltration in a breast cancer patient.
Topics: Adult; Breast Neoplasms; Female; Humans; Liver; Liver Failure; Silybin; Silymarin; Vitamin E | 2014 |
Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Infusions, Intravenous; Interferon alpha-2; Interferon-alpha; Liver Failure; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Silybin; Silymarin; Time Factors; Treatment Failure; Viral Load | 2011 |